Serum sclerostin is an independent predictor of mortality in hemodialysis patients

BACKGROUND: Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. The purpose of this study was to test whether serum Scl would be associated with mortality...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Nephrol
Päätekijät: Gonçalves, Flávia Letícia Carvalho, Elias, Rosilene M, dos Reis, Luciene M, Graciolli, Fabiana G, Zampieri, Fernando Godinho, Oliveira, Rodrigo B, Jorgetti, Vanda, Moysés, Rosa MA
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4265422/
https://ncbi.nlm.nih.gov/pubmed/25465028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-15-190
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia